Acantholytic Squamous Cell Carcinoma: Is It Really a More-Aggressive Tumor?


Source: Dermatologic Surgery, Volume 37, Number 3, March 2011 , pp. 353-356(4)

Publisher: Wiley-Blackwell

Buy & download fulltext article:


Price: $48.00 plus tax (Refund Policy)



Acantholytic squamous cell carcinoma (ASCC) is frequently considered to be a more-aggressive variant with worse prognosis than other squamous cell carcinoma (SCC) subtypes. OBJECTIVES

To analyze the biologic behavior of ASCC. METHODS

We conducted a literature search of articles in English plus a manual search of cited references and common dermatology textbooks. RESULTS

We found no comprehensive study on the biologic behavior of ASCC. Published data are scant, anecdotal, and contradictory. Of the articles investigated, the recurrence and metastasis rates ranged from 6% to 10% and 2% to 43%, respectively. CONCLUSION

Analysis of the published evidence does not support the assumption that ASCC is a more-aggressive tumor with higher potential for recurrence or metastasis. As with other SCC types, prognosis is more dependent on the characteristics of the host and the location, size, depth, differentiation, and previous treatment of tumors. The treatment and follow-up of patients with ASCC should be similar to those for other types of SCC.

The authors have indicated no significant interest with commercial supporters.

Document Type: Research Article


Affiliations: Department of Dermatology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma

Publication date: March 1, 2011

Related content



Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page